Healthcare Sectors

---

Pharmaceutical,Insurance companies and healthcare payers face increasing demands from healthcare providers for the right compensation of the care delivered, while, at the same time, are not always able to pass all those ever-increasing demands to their insured customers or final payers.

The need for conducting RWE studies to inform decisions regarding Healthcare Technology Assessments is increasing rapidly. As such the ability to use RWE at scale to conduct emulation trials or effectiveness studies regarding health technologies and interventions is becoming paramount for label reviews.

SIGIL is the right solution to address these challenges timely and effectively.